Publication:
Neoadjuvant (induction) chemotherapy in advanced bladder carcinoma

Simple item page
dc.contributor.authorsTürkeri, L.; Ilker, Y.; Simşek, F.; Akdaş, A.
dc.date.accessioned2022-03-28T12:45:53Z
dc.date.accessioned2026-01-11T06:06:13Z
dc.date.available2022-03-28T12:45:53Z
dc.date.issued1993
dc.description.abstractTraditional approaches for the treatment of locally advanced bladder tumours may not be sufficient enough. Neoadjuvant chemotherapy, a new modality, may be beneficial by enhancing the local and systemic control of the disease. The background of this new modality and early results of various trials are discussed.
dc.identifier.issn0301-1623
dc.identifier.pubmedPMID: 8225827
dc.identifier.urihttps://hdl.handle.net/11424/255045
dc.language.isoeng
dc.relation.ispartofInternational Urology and Nephrology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHumans
dc.subjectUrinary Bladder Neoplasms
dc.subjectDoxorubicin
dc.subjectMethotrexate
dc.subjectSurvival Rate
dc.subjectAntineoplastic Combined Chemotherapy Protocols
dc.subjectVinblastine
dc.subjectCyclophosphamide
dc.subjectChemotherapy, Adjuvant
dc.subjectOrganoplatinum Compounds
dc.titleNeoadjuvant (induction) chemotherapy in advanced bladder carcinoma
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage263
oaire.citation.startPage259
oaire.citation.titleInternational Urology and Nephrology
oaire.citation.volume3

Files

Collections

Araştırma Çıktıları